13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001012975-25-000445
Total Value
$305.7M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F | 922042775 | 2,142,684 | $144.0M | 47.11% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $135.0M | 44.17% |
| 3 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $10.0M | 3.28% |
| 4 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $7.4M | 2.42% |
| 5 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $2.8M | 0.91% |
| 6 | SPDR S&P 500 ETF TR | SPY | 4,104 | $2.5M | 0.83% |
| 7 | ALECTOR INC | ALEC | 1,307,858 | $1.8M | 0.60% |
| 8 | SURROZEN INC | SRZNW | 87,696 | $784,002 | 0.26% |
| 9 | RAPT THERAPEUTICS INC | 75382E208 | 82,234 | $657,872 | 0.22% |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $620,799 | 0.20% |
| 11 | SURROZEN INC | SRZNW | 170,833 | $3,092 | 0.00% |